Sign in

CIK 0001681087 · Non-accelerated filer<br>Smaller reporting company

Tectonic Therapeutic, Inc.

Sign in to watch
Ticker
TECX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NY
Entity type
operating
EIN
810710585
Phone
(339) 666-3320
Business address
490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
Former names
AvroBio, Inc., AVROBIO, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$13,920
in 2 filings, $14K under 10b5-1 plans

Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. McNamara Peter −$14K Chief Scientific Officer sold 1% of stake

Reading 86 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-03-04 Ruddy Marcella K. Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +24,250 24,250
2026-03-04 McNamara Peter Chief Scientific Officer Grant or award 10b5-1 +23,000 60,482
2026-03-04 McNamara Peter Chief Scientific Officer Sale 10b5-1 −1,650 $25.00 $41K 58,832
2026-03-04 McNamara Peter Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) 10b5-1 +21,000 21,000
2026-03-04 Schwabish Marc Chief Business Officer Grant or award +19,500 45,314
2026-03-04 Schwabish Marc Chief Business Officer Grant or award · Employee Stock Option (Right to Buy) +17,750 17,750
2026-03-04 Lochner Daniel Chief Financial Officer Grant or award +26,500 58,544
2026-03-04 Lochner Daniel Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +24,250 24,250
2026-03-04 REICIN ALISE Chief Executive Officer Grant or award +76,500 311,547
2026-03-04 REICIN ALISE Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +69,250 69,250
2026-03-03 McNamara Peter Chief Scientific Officer Sale 10b5-1 −1,649 $22.06 $36K 37,482
2026-02-11 REICIN ALISE Chief Executive Officer Purchase +2,500 $21.10 $53K 127,030
2026-02-11 REICIN ALISE Chief Executive Officer Purchase +2,500 $21.10 $53K 237,547
2026-02-10 Schwabish Marc Chief Business Officer Option exercise +4,500 $2.38 $11K 25,814
2026-02-10 Schwabish Marc Chief Business Officer Option exercise · Employee Stock Option (Right to Buy) −4,500 82,014
2026-02-10 Lochner Daniel Chief Financial Officer Purchase +6,000 $21.61 $130K 32,044
2026-02-04 Ruddy Marcella K. Chief Medical Officer Shares withheld for taxes −2,064 $23.22 $48K 53,247
2026-02-04 McNamara Peter Chief Scientific Officer Shares withheld for taxes −1,748 $23.22 $41K 39,131
2026-02-04 Schwabish Marc Chief Business Officer Shares withheld for taxes −1,619 $23.22 $38K 21,314
2026-02-04 Lochner Daniel Chief Financial Officer Shares withheld for taxes −2,077 $23.22 $48K 26,044

Page 3 of 10 · 188 trades